This commentary revisits the
political turmoil and scientific controversy over epidemiological study
findings linking high HIV seroincidence to syringe exchange attendance in
Vancouver in the mid-1990s. The association was mobilized polemically by US
politicians and hard-line drug warriors to attack needle exchange policies and
funding. In turn, program restrictions limiting access to syringes at the
Vancouver exchange may have interfaced with a complex conjunction of historical,
geographic, political economic and cultural forces and physiological
vulnerabilities to create an extraordinary HIV risk environment:
- ghettoization of services for indigent populations in a rapidly gentrifying, post-industrial city;
- rural-urban migration of vulnerable populations subject to historical colonization and current patterns of racism; and
- the flooding of North America with inexpensive powder cocaine and heroin, and the popularity of crack.
The tendency for modern social epidemiology to decontextualize
research subjects and assign excessive importance to discrete, "magic
bullet" variables resulted in a counterproductive scientific and political
debate in the late 1990s that has obfuscated potentially useful practical
lessons for organizing the logistics of harm reduction services - especially
syringe exchange - to better serve the needs of vulnerable populations and to
mitigate the effects of political-economically imposed HIV risk environments.
We would benefit from humbly acknowledging the limits of public health science
and learn to recognize the unintended consequences of well-intentioned
interventions rather than sweep embarrassing histories under the rug.
Purchase full article at: http://goo.gl/FubNuW
By: Ciccarone D1, Bourgois P2.
1Family and Community Medicine, UCSF 500 Parnassus
Avenue, MU-3E, Box 0900, San Francisco, CA 94143-0900, United States.
Electronic address: Daniel.Ciccarone@ucsf.edu.
2Psychiatry, Center for Social Medicine, UCLA, 760
Westwood Plaza, B7-435, Los Angeles, CA 90025, United States.
Int J Drug Policy. 2016 Mar 8.
pii: S0955-3959(16)30060-3. doi: 10.1016/j.drugpo.2016.02.028.
More at: https://twitter.com/hiv insight
No comments:
Post a Comment